Poland, M.( M. Poland)
tranilast patient restenosi trial group placebo study angiographic treatment follow-up vessel placebo group frequency angiographic restenosis laboratory month lesion target table point result stenosi treatment groups efficacy 3 months efficacy end point angioplasty university difference circulation figure stent value population reduction randomized angiography analysis revascularization heart 9 months substudy hepatic prevention abnormality holme effect outcome system hospital diameter 1.2 tranilast treatment body system jeffrey creatinine end points 0.7 procedure tranilast groups 1 mo placebo study medication angiographic subset angiographic substudy target vessels growth factor tamai 0.77 coll cardiol david analyses event tranilast group occurrence subset mace outcome differences heart j investigator artery balloon angioplasty
1 Most Recent Publications
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial
Holmes Jr, D.R. Granett, J.R. Davis, B.R. Poland, M. Zeiher, A.M. Willerson, J.T. King 3rd, S.B. Shapiro, L.M. Savage, M. Lablanche, J.M. Tcheng, J.E. Grip, L. Popma, J.J. Serruys, P.W.J.C. Fitzgerald, P.J. Fischman, D. Ferguson, J.J. Lincoff, A.M. Goldberg, S. Brinker, J.A. Chan, R.